Cargando…
Association between Inhaled β(2)-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study
PURPOSE: Despite ample evidence underpinning the efficacy of β(2)-agonists in asthma and chronic obstructive pulmonary disease (COPD), the occurrence of β(1)- and β(2)-adrenoceptors in the heart suggests that β(2)-agonists may have deleterious cardiac effects. We investigated the association between...
Autores principales: | Amegadzie, Joseph Emil, Gamble, John-Michael, Farrell, Jamie, Gao, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130098/ https://www.ncbi.nlm.nih.gov/pubmed/35645559 http://dx.doi.org/10.2147/COPD.S358927 |
Ejemplares similares
-
Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap
por: Amegadzie, Joseph Emil, et al.
Publicado: (2022) -
Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study
por: Amegadzie, Joseph Emil, et al.
Publicado: (2020) -
Validated methods to identify patients with asthma–COPD overlap in healthcare databases: a systematic review protocol
por: Amegadzie, Joseph Emil, et al.
Publicado: (2019) -
Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis
por: Xia, Ning, et al.
Publicado: (2015) -
Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)